Clinical Trial Update: Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating eltrombopag for thrombocytopenia in chronic lymphocytic leukemia patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: University of Ulm | Conditions: Chronic Lymphocytic Leukemia, Thrombocytopenia | Phase 1, Phase 2 | Status: TERMINATED